Skip to main content
. 2014 Jul;58(7):4014–4019. doi: 10.1128/AAC.02521-14

TABLE 1.

Baseline subject characteristics (ITT population)

Parameter Value for subjects receiving:
Value for all subjects (n = 82)
Rifalazil, 25 mg (n = 40) Azithromycin, 1 g (n = 42)
Age (yr)
    Mean (SD) 24.3 (4.76) 23.5 (4.51) 23.9 (4.62)
    Median 23.7 22.0 22.7
    Range 19–43 19–39 19–43
BMI (kg/m2)
    Mean (SD) 27.4 (7.84) 28.4 (9.34) 27.9 (8.61)
    Median 25.0 26.6 26.0
    Range 17–51 18–59 17–59
Race [no. (%)]
    White 17 (42.5) 18 (42.9) 35 (42.7)
    Black or African American 20 (50.0) 22 (52.4) 42 (51.2)
    Asian 2 (5.0) 0 (0.0) 2 (2.4)
    Other 1 (2.5) 2 (4.8) 3 (3.7)
Ethnicity [no. (%)]
    Hispanic or Latino 8 (20.0) 7 (16.7) 15 (18.3)
    Not Hispanic or Latino 32 (80.0) 35 (83.3) 67 (81.7)
Marital status [no. (%)]
    Divorced 1 (2.5) 3 (7.1) 4 (4.9)
    Married 3 (7.5) 1 (2.4) 4 (4.9)
    Single 36 (90.0) 38 (90.5) 74 (90.2)
Baseline N. gonorrhoeae test result [no. (%)]
    Negative 39 (97.5) 40 (95.2) 79 (96.0)
    Positive 1 (2.5) 2 (4.8) 3 (4.0)
Chlamydia episodes in preceding 1 yr [no. (%)]
    0 32 (80.0) 34 (81.0) 66 (80.5)
    1 7 (17.5) 7 (16.7) 14 (17.1)
    2 1 (2.5) 0 (0.0) 1 (1.2)
    3 0 (0.0) 1 (2.4) 1 (1.2)
STIs in preceding 1 yr [no. (%)]
    0 20 (50.0) 19 (45.2) 39 (47.6)
    1–2 17 (42.5) 17 (40.5) 34 (41.5)
    3 or more (maximum of 12) 3 (7.5) 6 (14.3) 9 (11.0)